The combination of HE4 and CA-125 is superior to either marker alone for monitoring women with ovarian cancer

Authors :: A.M. Blackman
A. Samborski
Richard G. Moore
A.L. Jackson
Elizabeth E. Eklund
Geralyn Messerlian
S. MacLaughlan David
M.C. Miller
Source :: Gynecologic Oncology. 159:97
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
medicine
Obstetrics and Gynecology
Ovarian cancer
medicine.disease
business

Tools